Notice of Registration - 2013
[Federal Register Volume 78, Number 35 (Thursday, February 21, 2013)]
[Notices]
[Pages 12103-12104]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-03881]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration;
Cody Laboratories, Inc.
By Notice dated November 1, 2012, and published in the Federal
Register on November 9, 2012, 77 FR 67398, Cody Laboratories, Inc.,
ATTN: Richard Asherman, 601 Yellowstone Avenue, Cody, Wyoming 82414,
made application by renewal to the Drug Enforcement Administration
(DEA) to be registered as a bulk manufacturer of the following basic
classes of controlled substances:
| Drug |
Schedule |
| Dihydromorphine (9145) |
I |
| Amphetamine (1100) |
II |
| Methamphetamine (1105) |
II |
| Amobarbital (2125) |
II |
| Pentobarbital (2270) |
II |
| Secobarbital (2315) |
II |
| 4-Anilino-N-phenethyl-4-piperidine (ANPP) (8333) |
II |
| Phenylacetone (8501) |
II |
| Cocaine (9041) |
II |
| Codeine (9050) |
II |
| Dihydrocodeine (9120) |
II |
| Oxycodone (9143) |
II |
| Hydromorphone (9150) |
II |
| Diphenoxylate (9170) |
II |
| Ecgonine (9180) |
II |
| Hydrocodone (9193) |
II |
| Meperidine (9230) |
II |
| Methadone (9250) |
II |
| Morphine (9300) |
II |
| Thebaine (9333) |
II |
| Oxymorphone (9652) |
II |
| Alfentanil (9737) |
II |
| Remifentanil (9739) |
II |
| Sufentanil (9740) |
II |
| Fentanyl (9801) |
II |
[[Page 12104]]
The company plans on manufacturing the listed controlled substances
in bulk for sale to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a), and determined that the registration
of Cody Laboratories, Inc., to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Cody Laboratories, Inc., to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history.
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: February 8, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2013-03881 Filed 2-20-13; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
